Yohannes Tesfaigzi to Treatment Outcome
This is a "connection" page, showing publications Yohannes Tesfaigzi has written about Treatment Outcome.
Connection Strength
0.088
-
Sun CY, Tesfaigzi Y, Lee GY, Chen YH, Weiss ST, Ma KS. Clinical effectiveness and safety of dupilumab in patients with chronic obstructive pulmonary disease: A?7-year population-based cohort study. J Allergy Clin Immunol. 2025 Jan; 155(1):219-222.e1.
Score: 0.040
-
Polverino F, Wu TD, Rojas-Quintero J, Wang X, Mayo J, Tomchaney M, Tram J, Packard S, Zhang D, Cleveland KH, Cordoba-Lanus E, Owen CA, Fawzy A, Kinney GL, Hersh CP, Hansel NN, Doubleday K, Sauler M, Tesfaigzi Y, Ledford JG, Casanova C, Zmijewski J, Konhilas J, Langlais PR, Schnellmann R, Rahman I, McCormack M, Celli B. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. Am J Respir Crit Care Med. 2021 09 15; 204(6):651-666.
Score: 0.033
-
Chand HS, Schuyler M, Joste N, Hensler C, Tesfaigzi Y, Masten B, Schrader R, Lipscomb MF. Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways. J Allergy Clin Immunol. 2010 May; 125(5):1157-1158.e5.
Score: 0.015